Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Insurance · CIK 0000059558
$41.11
+1.78% · delayed ~15 min
Last price from Oct 22, 2026
$7.81B market value
From LINCOLN NATIONAL CORP's FY2025 10-K, filed Feb 19, 2026 · read the filing
LINCOLN NATIONAL sells insurance. It took in $18.21B last year, which makes it a large company. Of every dollar it sells, about 6 cents is left as profit.
The financial picture is mixed, with profitability needing attention and growth and debt weaker.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
Several areas of financial weakness.
From LINCOLN NATIONAL CORP's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Profit
$3.27B → $1.18B
Profit margin
17.8% → 6.5%
Earnings per share
$19.22 → $6.19
Cash
$5.80B → $9.50B
Measured against FY2024, from the 10-K filed Feb 19, 2026
Deteriorated: -64.1%
$3.27B to $1.18BCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
LNC rose 1.78% on the latest quote. The average Financials company tracked here moved +1.10%, and the S&P 500 −1.04%. That is 0.7 points above its sector and 2.8 points above the market.
No filing from LNC and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 19 analysts covering this company, as of . Their views, not this site's.
Of 19 analysts publishing on this company, 2 say strong buy, 7 say buy, 8 say hold, 1 say sell and 1 say strong sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 6 cents of every dollar of sales as profit, earning $1.18B last year. Note that operations still consumed cash despite the reported profit.
No. Sales shrank 1.2% last year.
For every $1 it owes, it owns $1.03 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 28 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $1.18B and generated -$167.0M of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 19, 2026Filing for FY2025 | FY202410-K · Feb 21, 2025Filing for FY2024 | FY202310-K · Feb 21, 2025Filing for FY2023 | FY202210-K · Feb 21, 2025Filing for FY2022 | FY202110-K/A · Feb 22, 2024Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $18.21B | $18.44B | $11.64B | $18.81B | $17.71B | −1.2% |
| Selling, general and administrative | $2.65B | $2.74B | $2.54B | $2.41B | $2.25B | −3.3% |
| Interest expense | $227.0M | $336.0M | $331.0M | $283.0M | $270.0M | −32.4% |
| Income before tax | $1.34B | $4.02B | -$1.15B | $1.73B | $4.64B | −66.7% |
| Net income | $1.18B | $3.27B | -$752.0M | $1.36B | $3.78B | −64.1% |
| Net marginNet income ÷ revenueWhat is this? | 6.5% | 17.8% | -6.5% | 7.2% | 21.3% | −11.3 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $6.19 | $19.22 | $-4.43 | $8.03 | $21.32 | −67.8% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| LNCLINCOLN NATIONAL CORP · this page | 3.3/10 | 2/7 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 56,220 shares ($2.5M) on or after .
Shares originally obtained via Option.
Filed notice to sell 53,681 shares ($2.4M) on or after .
Shares originally obtained via Option Exercise.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2026
Revenue +12.3% · Profit margin +12.0 pts · Profit +90.6% — against Q2 FY2025
Read the filingWrite down why you are following LINCOLN NATIONAL CORP, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 26 subsidiaries named in its 10-K, incorporated across 13 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from LNC's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 19, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 7 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 3.3 | 2/7 | 10-K, filed Feb 19, 2026 |
| FY2024 | 6.0 | 5/7 | 10-K, filed Feb 21, 2025 |
| FY2023 | 2.0 | 2/7 | 10-K, filed Feb 22, 2024 |
| FY2022 | 4.7 | 5/7 | 10-K, filed Feb 22, 2024 |
| FY2021 | 6.0 | 6/7 | 10-K/A, filed Mar 30, 2023 |
| FY2020 | 6.0 | 5/7 | 10-K, filed Feb 18, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
2 of 7 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 2 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: −11.3 pts
17.8% to 6.5%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -67.8%
$19.22 to $6.19Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +63.8%
$5.80B to $9.50BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: +11.5%
170.4M to 190.1MCritical
Why it matters: New shares divide the same company into more pieces, so each existing holding owns slightly less of it. Often pay for staff or an acquisition rather than anything wrong.
Changed: +5.9%
$307.0M to $325.0MNotable
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Jul 30, 2026 — read it.
Improved: +90.6%
$699.0M to $1.33BCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +12.0 pts
17.3% to 29.3%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: +88.7%
$3.69 to $6.96Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +42.3%
$7.14B to $10.16BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: +12.3%
$4.04B to $4.54BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: +12.1%
$5.77B to $6.46BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Jul 30, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: turned positive
-$172.0M to $1.33BCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +32.6 pts
-3.2% to 29.3%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: turned positive
-$0.90 to $6.96Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +38.4%
$7.34B to $10.16BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: -14.4%
$5.31B to $4.54BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: +8.3%
$5.97B to $6.46BNotable
Why it matters: Rising debt is not automatically bad — borrowing to build something that earns more than the interest is ordinary. It matters when it grows faster than the profit meant to service it.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 7.6% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 3.4x — investors pay $3.4 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| -1.2% |
| 6.5% |
| 6.64x |
| 37.25x |
| PFGPRINCIPAL FINANCIAL GROUP INC | 3.3/10 | 5/7 | -3.1% | 7.6% | 20.20x | 27.68x |
|---|
| GLGLOBE LIFE INC. | 7.3/10 | 6/7 | 3.7% | 19.4% | 13.37x | 4.16x |
|---|
| Median of peers | 5.3/10 | — | 0.3% | 13.5% | 16.79x | 15.92x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Filed notice to sell 11,000 shares ($500.1K) on or after .
Shares originally obtained via Executive Compensation.
Filed notice to sell 15,006 shares ($398.3K) on or after .
Shares originally obtained via Payment for services rendered.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Published results · Made a Regulation FD disclosure
Reported another event
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Revenue +13.1% · Profit margin +12.2 pts · Profit $550.0M narrower — against Q1 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingHad a director or senior officer leave or join
Read the filingProxy statement for a shareholder meeting
Read the filingSigned a material agreement
Read the filingAnnual report for FY2025
Profit margin −11.3 pts · Profit -64.1% · Earnings per share -67.8% — against FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingReported another event
Read the filingQuarterly report for Q3 FY2025
Revenue +10.8% · Profit margin +22.6 pts · Profit turned positive — against Q3 FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingQuarterly report for Q2 FY2025
Revenue -21.5% · Shares in issue +11.4% · Profit -21.9% — against Q2 FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingReported another event
Read the filingHad a director or senior officer leave or join · Amended its charter or changed its financial year · Held a shareholder vote
Read the filingTook on a direct financial obligation
Read the filingSource: Exhibit 21 of the 10-K filed 2026-02-19. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Lincoln National Has One Preferred: Hold-Rated At Best
SeekingAlpha ·
JP Morgan Maintains Underweight on Lincoln National, Lowers Price Target to $47
Benzinga ·
Lincoln National Series D Preferred Shares: Unlocking A 7.7% YTC
SeekingAlpha ·
Can The Hartford's Equitable Deal Strengthen Its Benefits Business?
Yahoo ·
Lincoln National: Why The Recovery Is Unlikely To Be Over
SeekingAlpha ·
Wells Fargo Maintains Overweight on Lincoln National, Raises Price Target to $54
Benzinga ·
3 US Life Insurer Stocks Worth Watching As Higher Treasury Yields Reset Profits
Yahoo ·
Keefe, Bruyette & Woods Maintains Outperform on Lincoln National, Lowers Price Target to $50
Benzinga ·
3 Cash-Heavy Stocks We Steer Clear Of
Yahoo ·
Mizuho Maintains Outperform on Lincoln National, Lowers Price Target to $49
Benzinga ·
Barclays Maintains Overweight on Lincoln National, Raises Price Target to $48
Benzinga ·
Evercore ISI Group Maintains In-Line on Lincoln National, Lowers Price Target to $51
Benzinga ·
Primary sources and further research